About Asthmatx
Asthmatx is a company based in Sunnyvale (United States) founded in 2003 was acquired by Boston Scientific in September 2010.. Asthmatx has raised $50 million across 1 funding round from investors including Boston Scientific and Olympus. Asthmatx operates in a competitive market with competitors including Nuvaira, RejuvenAir and D R Burton, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asthmatx Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 M (USD)
in 1 rounds
-
Latest Funding Round
$50 M (USD), Series D
May 15, 2007
-
Investors
Boston Scientific
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Boston Scientific
(Sep 20, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Asthmatx
Asthmatx has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series D round of $50 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $50.0M
-
First Round
First Round
(15 May 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2007 | Amount | Series D - Asthmatx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asthmatx
Asthmatx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Boston Scientific and Olympus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of imaging and surgical products
|
Founded Year | Domain | Location | |
|
Wide range of medical devices
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asthmatx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asthmatx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asthmatx Comparisons
Competitors of Asthmatx
Asthmatx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuvaira, RejuvenAir and D R Burton, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A catheter-based system for COPD treatment is developed and provided.
|
|
| domain | founded_year | HQ Location |
Cryosurgical device for chronic bronchitis and COPD treatment is developed.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive products for positive pressure therapy in lung disease patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Asthmatx
When was Asthmatx founded?
Asthmatx was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Where is Asthmatx located?
Asthmatx is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Asthmatx a funded company?
Asthmatx is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Series D of $50M, raised on May 15, 2007.
What does Asthmatx do?
Asthmatx is a medical device company, focuses on developing and commercializing a therapeutic treatment for asthma in the United States. The company has developed a technology that is designed to deliver controlled thermal radiofrequency energy to the airways of adult patients to reduce the mass of airway smooth muscle in a procedure called Bronchial Thermoplasty. Asthmatx offers an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma. The Alair Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well-controlled with inhaled corticosteroids and long-acting beta-agonist medicines. Patients are treated in multiple sessions, each targeting a different section of the airways.
Who are the top competitors of Asthmatx?
Asthmatx's top competitors include Nuvaira, RejuvenAir and D R Burton.
Who are Asthmatx's investors?
Asthmatx has 2 investors. Key investors include Boston Scientific, and Olympus.